Sit Less, Interact and Move More (SLIMM) 2 Study

NCT05173714 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

156

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Diseases
Obesity

Interventions

BEHAVIORAL: SLIMM
BEHAVIORAL: Standard Resistance Training
BEHAVIORAL: Guided Resistance Training
DRUG: Placebo
DRUG: Semaglutide

Sponsor

Srinvasan Beddhu

Collaborators

[object Object]
[object Object]